Career Center   |   Print Page   |   Contact Us   |   Sign In   |   Join SRNT
Plenary Speaker Lectures
Share |

Highlights of the 2019 SRNT Plenary Lecture Sessions

Mark your calendar to not miss the 2019 SRNT guest speakers this year!

Plenary Meeting Room Location: Grand Ballroom B (Grand Ballroom Level)


Wednesday, February 20, 2019

Time: 5:30 p.m. - 6:45 p.m.

Presidential Symposium
Tobacco Control for All: Addressing Smoking Disparities for Priority Populations

Session Chair: Marina Picciotto, PhD

Presenters:
Geoffrey Fong, PhD, Professor of Psychology and Public Health and Health Systems, University of Waterloo, Waterloo, Ontario, Canada; Senior Investigator, Ontario Institute for Cancer Research, Toronto, Ontario, Canada

Pebbles Fagan, PhD, MPH, Professor of Health Behavior and Health Education, and Director, Center for the Study of Tobacco, University of Arkansas for Medical Sciences, Little Rock, AK, USA 


Monica Webb Hooper, PhD, Professor of Oncology, Psychological Sciences, Family Medicine and Community Health, Case Western Reserve University; Associate Director for Cancer Disparities Research; Director, Office of Cancer Disparities Research, Case Comprehensive Cancer Center, Cleveland, OH, USA; Co-Chair of the SRNT Health Disparities Network

Andrew Waa, MPH, Ngāti Hine/Ngāpuh, Senior Research Fellow in Public Health, Eru Pomare Māori Health Research Centre, University of Otago, Dunedin, New Zealand

-- 
Linda Alexander, PhD, EdD, Senior Associate Dean for Academic, Student and Faculty Affairs; Professor, Social and Behavioral Sciences, West Virginia University, Morgantown, WV, USA


Thursday, February 21, 2019

Time: 8:30 a.m. - 9:30 a.m.



Basic Science Keynote Plenary
Nicotine During Adolescence: Mechanisms Leading to Long-Term Changes in Cognition

Session Chair:  Marina Picciotto, PhD

Presenter: Huib Mansvelder, PhD, Professor of Neurophysiology, Head of Department, Integrative Neurophysiology, Vrije Universiteit Amsterdam, The Netherlands

Huib Mansvelder received his PhD in Neurophysiology from the Vrije Universiteit Amsterdam in 1999. In his thesis, he investigated the control of large dense-core vesicle release by voltage-gated calcium channels in neuroendocrine cells in the pituitary. During his postdoctoral research with Dan McGehee at the University of Chicago, he studied drug-induced synaptic plasticity in dopamine neurons, and found mechanisms by which nicotinic receptors alter glutamatergic and GABAergic synaptic transmission in the VTA. During his second postdoc at Columbia University New York with Rafael Yuste, rapid calcium dynamics in dendritic spines were studied using 2photon imaging. In the summer of 2002, Huib started his own lab at VU University in Amsterdam. He became full professor in 2008 and heads the department of Integrative Neurophysiology since. His research focuses on how the prefrontal cortex orchestrates attention behaviour in rodents, in particular in interaction with subcortical brain areas, such as the basal forebrain, and how drugs of abuse such as nicotine affect these processes. In addition, his lab investigates how neuronal microcircuits in the human neocortex are organized, both anatomically as well as functionally, and how properties of human neurons relate to human cognition.



Thursday, February 21, 2019

Time: 1:00 p.m. - 1:30 p.m.  

Policy Keynote Plenary and Recipient of the 2019 Jarvik Russell Award
The Intersections Between Social Determinants of Health, Tobacco Marketing, Tobacco Control, and Tobacco Use

Session Chair: Andrea Villanti, PhD, MPH

Presenter: Kelvin Choi, PhD, MPH, National Institute on Minority Health and Health Disparities Division of Intramural Research, Bethesda, Maryland

Dr. Kelvin Choi is an Earl Stadtman Investigator at the Division of Intramural Research, National Institute on Minority Health and Health Disparities (NIMHD). Prior to joining NIMHD, he was an Assistant Professor at the University of Minnesota. Dr. Choi received his MPH in Community Health Education, and PhD in Social and Behavioral Epidemiology from the University of Minnesota. He was an invited attendee of the 2011 NIH Institute on Systems Science and Health, and 2012 NIH Training Institute for Dissemination and Implementation Research in Health. Dr. Choi’s research focuses on three objectives: (1) examining the disparities of tobacco use in the US population; (2) investigate factors that worsen and reduce tobacco use disparities, e.g., tobacco marketing and tobacco control; and (3) understand the impact of tobacco use behaviors on social determinants. His research has been published in over 60 articles in peer-reviewed journals and presented at over 100 conference presentations. Dr. Choi currently serves as the Co-chair of the Society for Research on Nicotine and Tobacco Health Disparities Network, and a member of the California Tobacco Control Program Evaluation Task Force. He has been recognized by the Tobacco Control and Nicotine & Tobacco Research as Reviewer of the Year. 



Thursday, February 21, 2019

Time: 1:30 p.m. - 2:30 p.m. 


Public Health Keynote Plenary

Session Chair: Judith Prochaska, PhD

Presenter: Eliseo J. Pérez-Stable, MD, Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH), Bethesda, Maryland

Eliseo J. Pérez-Stable, M.D. is Director of the National Institutes of Health’s National Institute on Minority Health and Health Disparities (NIMHD), which seeks to advance the science of minority health and health disparities research through research, training, research capacity development, public education, and information dissemination.  Dr. Pérez-Stable practiced general internal medicine for 37 years at the University of California, San Francisco (UCSF) before moving to NIH in September 2015.  He was professor of medicine at UCSF and chief of the Division of General Internal Medicine for 17 years. His research interests include improving the health of racial and ethnic minorities and underserved populations, advancing patient-centered care, improving cross-cultural communication skills among clinicians, and promoting diversity in the biomedical research workforce. For more than 30 years, Dr. Pérez-Stable led research on Latino smoking cessation and tobacco control policy in the United States and Latin America, addressing clinical and prevention issues in cancer screening, and mentoring over 70 minority investigators. He has published over 250 peer-reviewed articles and was elected to the National Academy of Medicine in 2001.

 

Friday, February 22, 2019

Time: 1:00 p.m.-2:30 p.m.

Awards Session 

Awards Chair: Tom Glynn, PhD

Clinical Keynote Plenary and Recipient of the 2019 Ove Ferno Award
Precision Therapy for Nicotine Dependence

Session Chair:  Robert Schnoll, PhD

Presenter: Caryn Lerman, PhD, Vice Dean for Strategic Initiatives, Perelmen School of Medicine, John H. Glick, MD, Professor in Cancer Research, Department of Psychiatry, University of Pennsylvania, USA

Dr. Caryn Lerman is the Vice Dean for Strategic Initiatives for Penn Medicine and the John H. Glick Professor in Cancer Research in the Department of Psychiatry.  Formerly, she served as the Co-Director of the Penn Medicine Translational Neuroscience Center and Deputy Director of the Abramson Cancer Center at Penn. She is nationally recognized for her research in the area of nicotine addiction medication development and precision therapy.  Her recent work harnesses advances in cognitive neuroscience to promote smoking behavior change, supported by an R35 National Cancer Institute Outstanding Investigator Award.

Dr. Lerman’s research is represented in more than 375 peer-reviewed publications as well as congressional testimonies and government reports.  Her honors include the APA Award for Outstanding Contributions to Health Psychology, the ASPO Cullen Award for Tobacco Research, the Ochsner Award for Research Relating Smoking and Health, and the NIH Matilda White Riley Award for Behavioral Science Research. She is past President of the Society for Research on Nicotine and Tobacco, and has served on the National Institute on Drug Abuse Advisory Council, the National Cancer Institute Board of Scientific Advisors, and the National Advisory Council for Human Genome Research. She is an elected member of the National Academy of Medicine/Institute of Medicine.

 

For the 2019 Schedule-At-A-Glance, click here

Connect With Us
Membership Management Software Powered by YourMembership  ::  Legal